Cited 0 times in
An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, MJ | - |
dc.contributor.author | Cho, JH | - |
dc.contributor.author | Sun, JM | - |
dc.contributor.author | Lee, SH | - |
dc.contributor.author | Ahn, JS | - |
dc.contributor.author | Park, K | - |
dc.contributor.author | Park, KU | - |
dc.contributor.author | Kang, EJ | - |
dc.contributor.author | Choi, YH | - |
dc.contributor.author | Kim, KH | - |
dc.contributor.author | An, HJ | - |
dc.contributor.author | Lee, HW | - |
dc.date.accessioned | 2020-08-20T00:04:49Z | - |
dc.date.available | 2020-08-20T00:04:49Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/18650 | - |
dc.language.iso | en | - |
dc.title | An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 이, 현우 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1200/JCO.2018.36.15_suppl.9050 | - |
dc.citation.title | Journal of clinical oncology | - |
dc.citation.volume | 36 | - |
dc.citation.number | 15S | - |
dc.citation.date | 2018 | - |
dc.citation.startPage | 9050 | - |
dc.citation.endPage | 9050 | - |
dc.identifier.bibliographicCitation | Journal of clinical oncology, 36(15S). : 9050-9050, 2018 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.relation.journalid | J00732183X | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.